Michael Shalmi
Board member
Pharmaceuticals
Orexo
Sweden
Biography
Managing Director and Head of Large Investments, Novo Holdings A/S. 15 years at Novo Nordisk; V.P. International Marketing, Corporate VP Haemostasis and Chief Medical Officer BioPharm, V.P. of Haematology Business Unit, V.P. BioPharm Business Unit, and Corporate V.P. Global Development, Clinical Operations Management at Novo Nordisk HQ. Does not hold any shares in Orexo, as of Decemb
Research Interest
BioPharm Business